RE: Today's report15 Oct 2025 11:26
Fair enough, I have read it. I thought you might have another source.
Anyway PSE still needs to get into the mainstream :
The TRANSFORM study starting in 2025 will compare multiple screening options to each other and the current
system, to find the safest, most accurate and most cost-effective way to screen men for prostate cancer. In
stage one, involving around 13,500 men, researchers will compare four potential screening options, including
fast MRI scans, genetic testing to identify men at high risk of prostate cancer and PSA blood testing. A fast
MRI is a biparametric MRI (bpMRI), a 12-minute version of the full scan to produce a detailed picture of the
prostate.14 Recent evidence has been published to demonstrate the non-inferiority of bpMRI versus mpMRI when
diagnosing clinically significant prostate cancer. The inclusion of bpMRI as part of a screening programme would
mean that scans could be performed outside of the secondary care setting without the need for a clinician to be
present, potentially leading to reduced expense and higher throughput than that seen with mpMRI scans.13
The TRANSFORM study has not yet commenced and will report out at intervals over the next 15 years.